Renal dysfunction – predictor for prognosis in patients with st-segment elevation acute myocardial infarction


K.A. Vakulchik, E.M. Mezhonov, Yu.A. Vyalkina, S.V. Shalaev

1 FSBEI HE "Tyumen State Medical University" of RMH, Department of Cardiology and Cardiac Surgery with the Course of Emergency Medical Care of the Institute of Continuous Professional Education, Tyumen, Russia; 2 SBHCI TR "Regional Clinical Hospital №1", Tyumen, Russia

Aim. to evaluate the prognostic value of kidney damage in patients with ST-segment elevation acute myocardial infarction (STEMI) in a prospective 6-month observational study.


Material and Methods. A prospective 6-month observational study included 241 patients with STEMI. The kidney function was evaluated by calculating the creatinine clearance using the CKD-EPI formula. An evaluation of the effect of renal dysfunction on CAD outcomes for 6 months was carried out. The endpoints of the study included: hospital mortality, cardiovascular mortality during follow-up, readmissions for acute coronary syndrome (ACS).


Results. 41.1% of patients had renal dysfunction (GFR <60 mL/min). Hospital mortality was rec-orded in 9.5% of cases; the highest mortality rate was recorded in the group of patients with GFR <60 ml/min – 17.2%, while among patients with GFR> 60 ml/min – 4.2% (p=0.001). Hospital mor-tality with GFR from 45 to 59 ml/min was 6.3%, GFR from 30 to 44 ml/min – 42.9%, GFR from 15 to 29 ml/min – 60.0% (p<0.001). GFR <60 ml/min increases the risk of the combined primary end-point by 3 times (RR 95% 2.917 (1.360–6.254, p=0.006), GFR from 45 to 30 ml/min – by 8 times (RR 95% 7.714 (2,076–28,661, p=0,002), and GFR from 30 to 15 ml/min – by 10 times (RR 95% 10,286 (2,383–44,398, p=0,002).


Conclusions. In patients with STEMI, a decrease in GFR is an unfavorable predictor of fatal out-come within 6 months of follow-up.


About the Autors


Vakulchik K.A. – Postgraduate Student at the Department of Cardiology and Cardiac Surgery of the ICPE with a Course of EMC FSBEI HE "Tyumen SMU" of RMH, Tyumen,
Russia. E-mail: vakulchik_91@mail.ru
Mezhonov E.M. – PhD in Medical Sciences, Cardiologist at the SBHCI TR "RCH №1", Tyumen, Russia
Vyalkina Yu.A. – PhD in Medical Sciences, Cardiologist at the SBHCI TR "RCH №1", Tyumen, Russia
Shalaev S.V. – Doctor of Medical Sciences, Professor, Head of the Department of Cardiology and Cardiac Surgery with the Course of EMC of the ICPE FSBEI HE "Tyumen
SMU" of RMH, Chief Cardiologist of the Healthcare Department of the Tyumen Region


Similar Articles


Бионика Медиа